title: Response to letter "Do all hypnotic drugs and sedatives have risk for cancer?".
authors.affiliation: Division of Mental Health, Norwegian Institute of Public Health, Bergen, Norway; Regional Centre for Child and Youth Mental Health and Child Welfare, Uni Research Health, Bergen, Norway; Department of Psychiatry, Helse Fonna HF, Haugesund, Norway. Electronic address: borge.sivertsen@fhi.no.
authors.forename: Børge
authors.initials: B
authors.lastname: Sivertsen
authors.affiliation: Public Sector Research Centre, Finnish Institute of Occupational Health, Turku, Finland; Department of Psychology, University of Turku, Turku, Finland.
authors.forename: Paula
authors.initials: P
authors.lastname: Salo
authors.affiliation: Public Sector Research Centre, Finnish Institute of Occupational Health, Turku, Finland.
authors.forename: Jaana
authors.initials: J
authors.lastname: Pentti
authors.affiliation: Department of Epidemiology and Public Health, University College London Medical School, London, UK; Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
authors.forename: Mika
authors.initials: M
authors.lastname: Kivimäki
authors.affiliation: Public Sector Research Centre, Finnish Institute of Occupational Health, Turku, Finland; Department of Public Health, University of Turku and Turku University Hospital, Turku, Finland.
authors.forename: Jussi
authors.initials: J
authors.lastname: Vahtera
mesh_terms: D006801:Humans; D006993:Hypnotics and Sedatives; D009369:Neoplasms; D012306:Risk
chemical_list: D006993:Hypnotics and Sedatives